Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

  title={Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact},
  author={A Pali S Hungin and L. Chang and Giles Richard Locke and Eslie Dennis and Victoria Barghout},
  journal={Alimentary Pharmacology \& Therapeutics},
Background : The impact of irritable bowel syndrome, a gastrointestinal motility disorder, is underestimated and poorly quantified, as clinicians may see only a minority of sufferers. 

Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey

This work has shown clear trends in the prevalence and demographics of irritable bowel syndrome among women over the age of 40, and these trends have continued to improve since the 1970s.

Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care – A Rome Foundation Working Team Report

To review studies on the perceptions, diagnosis and management of irritable bowel syndrome (IBS) in primary care, a large number of studies from around the world have been reviewed.

Meeting the challenge of IBS.

This study highlights the need to understand more fully the mechanism behind the development and management of irritable bowel syndrome, which is often characterized by crippling symptoms without any pathologic findings.

The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study

The natural history of irritable bowel syndrome in Denmark over 3 years was explored by studying development of IBS symptoms and associated factors.

Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction, Based on IBS in America Survey.

Many treatments for irritable bowel syndrome are available to those with the disease, but satisfaction is low, and a need exists for further effective treatments for the condition.

Meta‐analysis: do irritable bowel syndrome symptoms vary between men and women?

This data indicates that sex and gender‐related differences exist in irritable bowel syndrome (IBS), but data is often conflicting and research is needed to confirm these differences.

Significant psychological morbidity occurs in irritable bowel syndrome: a case‐control study using a pharmacy reimbursement database

A large number of patients with psychological problems are diagnosed with IBS, but the strength of this association is unclear and the causes are still poorly understood.

In‐patient discharge rates for the irritable bowel syndrome – an analysis of national trends in the United States from 1997 to 2010

There are limited data on the rate and costs associated with in‐patient discharges for IBS, and the most common out‐patient diagnoses in primary care and gastroenterology is IBS.

Irritable Bowel Syndrome

ABSTRACT Questions from patients about analgesic pharmacotherapy and responses from the authors are presented to help educate patient sand make them more effective self-advocates. The topics

Irritable Bowel Syndrome: Prevalence, Type and Associated Factors among Male Adult residents at Al-Iskan Avenue in Makkah Almukarramah, Saudi Arabia

The etiology of irritable bowel syndrome remains uncertain or obscure, perhaps multifactorial, and several hypotheses attempt to account for the pathophysiology of IBS.



The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects

To determine the prevalence, symptom pattern and impact of the irritable bowel syndrome, across eight European countries, using a standardized methodology, the aim was to establish a standard methodology and establish a baseline for this study.

AGA technical review on irritable bowel syndrome.

Psychosocial factors, although not part of IBS per se, have an important role in modulating the illness experience and its clinical outcome.

Management of irritable bowel syndrome.

Episodes of diarrhea are best managed with loperamide, while constipation often will respond to fiber supplements, and antispasmodics or anticholinergic agents may help relieve the abdominal pain of irritable bowel syndrome.

Women With Irritable Bowel Syndrome: Differences in Patients’ and Physicians’ Perceptions

A national survey was undertaken to describe the attitudes, knowledge, treatment strategies, and compliance of women with IBS, and determine whether physician gender influenced patient satisfaction.

The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus

This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion.

Clinical Assessment of Irritable Bowel Syndrome

Because irritable bowel syndrome (IBS) is a prevalent cause of visits to the gastroenterologist, it is extremely important to have accurate guidelines for the diagnosis. During the clinical

Irritable bowel syndrome: definition, diagnosis and epidemiology.

  • N. Talley
  • Medicine
    Bailliere's best practice & research. Clinical gastroenterology
  • 1999
The development of acceptable, symptom-based diagnostic criteria has advanced the field, stimulating interest in the pathophysiology and targeted pharmacological therapy, which are essential steps if the disease burden is to be reduced.

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Multivariate statistical analyses suggest that gastrointestinal disorders, psychiatric disorders, and nongastrointestinal somatic disorders are distinct disorders and not manifestations of a common somatization disorder, but their strong comorbidity suggests a common feature important to their expression, which is most likely psychological.

Review article: irritable bowel syndrome

Irritable bowel syndrome is the most common disease diagnosed by gastroenterologists and affects about 20% of all people at any one time; the illness has a large economic impact on health‐care utilization and absenteeism.

Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures.

It has been suggested that the annual direct costs for irritable bowel syndrome (IBS) are now around $US41 billion in the 8 most industrialised countries. This paper reviews the data on calculations